4//SEC Filing
Mauro David J 4
Accession 0001209191-23-035239
CIK 0001601830other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:36 PM ET
Size
7.5 KB
Accession
0001209191-23-035239
Insider Transaction Report
Form 4
Mauro David J
Chief Medical Officer
Transactions
- Award
Class A Common Stock
2023-06-01+190,713→ 190,713 total - Award
Stock Option (Right to Buy)
2023-06-01+381,426→ 381,426 totalExercise: $8.77Exp: 2033-06-01→ Class A Common Stock (381,426 underlying)
Footnotes (2)
- [F1]This RSU vests as to one fourth (1/4th) of the units subject to the RSU on August 15, 2024 and one sixteenth (1/16th) every three months thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
- [F2]This option vests as to one fourth (1/4th) of the shares subject to the option on June 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001621172
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 7:36 PM ET
- Size
- 7.5 KB